Regeneron Pharmaceuticals | Custo De Mercadoria Vendida

Preço das Ações
803.17
Mudança Diária
19.52 2.49%
Mensal
6.50%
Anual
19.24%
Q1 Previsão
778.27




Custo de Mercadoria Vendida Alterar Data
AbbVie USD 4.55B 757M 2025-12
Agenus USD 137K 19K 2025-03
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
Astellas Pharma JPY 149.13B 10.88B 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Ionis Pharmaceuticals USD 2.34M 1.81M 2025-09
J&J USD 7.97B 689M 2025-12
Kyowa Hakko Kirin JPY 37.87B 9.67B 2025-12
Merck USD 3.32B 531M 2025-12
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 217M 2025-09
Novartis USD 3.54B 216M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.76B 344M 2025-12
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
United Therapeutics USD 100.9M 74.3M 2025-09
Vertex Pharmaceuticals USD 466M 51.2M 2025-12


Regeneron Pharmaceuticals Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.